Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+30.28%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$116B
AUM Growth
+$12.9B
Cap. Flow
-$7.32B
Cap. Flow %
-6.32%
Top 10 Hldgs %
14.35%
Holding
3,987
New
586
Increased
1,423
Reduced
1,366
Closed
597

Top Buys

1
ZM icon
Zoom
ZM
+$1.14B
2
ABBV icon
AbbVie
ABBV
+$537M
3
TMUS icon
T-Mobile US
TMUS
+$504M
4
BIDU icon
Baidu
BIDU
+$474M
5
KR icon
Kroger
KR
+$448M

Sector Composition

1 Healthcare 23.45%
2 Technology 16.11%
3 Consumer Staples 10.59%
4 Consumer Discretionary 9.95%
5 Communication Services 9.52%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PHAS
2801
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$605K ﹤0.01%
131,500
-31,700
-19% -$146K
TLH icon
2802
iShares 10-20 Year Treasury Bond ETF
TLH
$11.6B
$602K ﹤0.01%
3,600
+1,000
+38% +$167K
HUSN
2803
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
$602K ﹤0.01%
432,340
+83,263
+24% +$116K
QTEC icon
2804
First Trust NASDAQ-100 Technology Index Fund
QTEC
$2.74B
$600K ﹤0.01%
+5,500
New +$600K
CATX icon
2805
Perspective Therapeutics
CATX
$255M
$599K ﹤0.01%
107,805
+39,389
+58% +$219K
TRNS icon
2806
Transcat
TRNS
$694M
$599K ﹤0.01%
23,163
-5,623
-20% -$145K
VMD icon
2807
Viemed Healthcare
VMD
$264M
$597K ﹤0.01%
62,200
+41,700
+203% +$400K
TMV icon
2808
Direxion Daily 20+ Year Treasury Bear 3X Shares
TMV
$162M
$594K ﹤0.01%
+46,000
New +$594K
IRD
2809
Opus Genetics, Inc. Common Stock
IRD
$81.5M
$594K ﹤0.01%
52,325
+5,884
+13% +$66.8K
MYGN icon
2810
Myriad Genetics
MYGN
$688M
$590K ﹤0.01%
+52,000
New +$590K
FXH icon
2811
First Trust Health Care AlphaDEX Fund
FXH
$924M
$586K ﹤0.01%
+6,500
New +$586K
SNOA icon
2812
Sonoma Pharmaceuticals
SNOA
$7.43M
$586K ﹤0.01%
4,112
+629
+18% +$89.6K
GAIA icon
2813
Gaia
GAIA
$152M
$580K ﹤0.01%
69,198
+14,898
+27% +$125K
ESQ icon
2814
Esquire Financial Holdings
ESQ
$835M
$576K ﹤0.01%
34,106
+6,749
+25% +$114K
RUHN
2815
DELISTED
Ruhnn Holding Limited American Depositary Shares
RUHN
$576K ﹤0.01%
193,400
+179,093
+1,252% +$533K
BOOM icon
2816
DMC Global
BOOM
$144M
$575K ﹤0.01%
20,851
-59,732
-74% -$1.65M
FINX icon
2817
Global X FinTech ETF
FINX
$301M
$575K ﹤0.01%
+17,300
New +$575K
MITT
2818
AG Mortgage Investment Trust
MITT
$246M
$573K ﹤0.01%
59,900
+18,433
+44% +$176K
RRGB icon
2819
Red Robin
RRGB
$122M
$573K ﹤0.01%
+56,166
New +$573K
VNTR
2820
DELISTED
Venator Materials PLC
VNTR
$573K ﹤0.01%
320,038
-216,700
-40% -$388K
ANF icon
2821
Abercrombie & Fitch
ANF
$4.13B
$572K ﹤0.01%
+53,800
New +$572K
EWC icon
2822
iShares MSCI Canada ETF
EWC
$3.26B
$572K ﹤0.01%
+22,100
New +$572K
BSJL
2823
DELISTED
Invesco BulletShares 2021 High Yield Corporate Bond ETF
BSJL
$572K ﹤0.01%
+25,189
New +$572K
TANH icon
2824
Tantech Holdings
TANH
$2.83M
$570K ﹤0.01%
49
-4
-8% -$46.5K
CCRN icon
2825
Cross Country Healthcare
CCRN
$414M
$566K ﹤0.01%
91,856
-202,526
-69% -$1.25M